Increased risk of a positive test for antibody to hepatitis B core antigen (anti‐HBC) in autologous blood donors

Brenda J. Grossman, Nadina C. Stewart, Alfred J. Grindon

Research output: Contribution to journalArticlepeer-review

29 Scopus citations

Abstract

ABSTRACT: Controversy exists about the suitability of blood from autologous donors for homologous use. We compared the infectious disease test results of 426 autologous donors, designated by donor history as suitable for homologous use, to those of 86,138 volunteer donations collected over the same 5 month period. Although donor characteristics differed, the relative risk of a positive test for anti‐HBc in the autologous group was 2.09. When 413 autologous donors were compared to 413 volunteer donors matched for age, sex, and zip code, the relative risk of a positive test for anti‐HBc in the autologous group was 3.2. If anti‐HBc is a marker for non‐A, non‐B hepatitis transmissibility, then our autologous group is not as safe as our volunteer donors. We recommend that autologous blood, even when designated by donor history and laboratory screening results as suitable for homologous transfusion, not be used for other than the intended autologous recipient. 1988 AABB

Original languageEnglish
Pages (from-to)283-285
Number of pages3
JournalTransfusion
Volume28
Issue number3
DOIs
StatePublished - Jan 1 1988

Fingerprint

Dive into the research topics of 'Increased risk of a positive test for antibody to hepatitis B core antigen (anti‐HBC) in autologous blood donors'. Together they form a unique fingerprint.

Cite this